The Gary Null Show - 04.05.22

Vegan diet eases arthritis pain, finds new study   Physicians Committee for Responsible Medicine, April 4, 2022   A low-fat vegan diet, without calorie restrictions, improves joint pain in patients with rheumatoid arthritis, according to a new study conducted by researchers at the Physicians Committee for Responsible Medicine. Study participants also experienced weight loss and improved cholesterol levels. “A plant-based diet could be the prescription to alleviate joint pain for millions of people suffering from rheumatoid arthritis,” says Neal Barnard, MD, lead author of the study and president of the Physicians Committee. “And all of the side effects, including weight loss and lower cholesterol, are only beneficial.”   (NEXT)   Researchers Discover Cannabis-Mushroom Combination That “Kills Over 90% Of Colon Cancer Cells”   Cannabotech Integrative (Israel), April 1, 2022   For the last several years, scientists with Cannabotech, a biomedical company developing oncological products using cannabis, have been developing an “Integrative-Colon” product they say kills over 90% of colon cancer cells. According to Cannabotech, they have concluded a study using not only cannabis, but a unique combination of cannabinoids and mushroom extracts, which they tested on various colon cancer subtypes, representing different molecular changes common in these colon cancer subtypes. Their results of the cell model study were astounding, showing that its “Integrative-Colon” products killed over 90% of colon cancer cells — and they attribute this to to the mushroom and cannabis combination. Given the fact that the survival rate for colorectal cancer is just 65%, the idea that an easily grown plant and fungus could be used to save hundreds of thousands of lives, is inspiring to say the least. Humans share more DNA with mushrooms than we do with plants, a lot more.   (NEXT)   Vitamin C could help reduce toxic side effects of common cancer treatment    University Nove de Julho (Brazil), April 4, 2022   A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects. “Our results suggest vitamin C as a potential adjunct therapy to assist in the management of peripheral muscle disorders after treatment with doxorubicin, thereby improving functional capacity and quality of life and reducing mortality,” said Antonio Viana do Nascimento Filho, a master’s student in medicine at University Nove de Julho (UNINOVE) in Brazil, first author of the study. Nascimento Filho will present the findings at the American Physiological Societyannual meeting during the Experimental Biology (EB) 2022 meeting, held in Philadelphia April 2–5.   (NEXT)   Stress markers high, antioxidants low in breast cancer patients   University of Lahore (Pakistan), April 4 2022.    Research revealed blood inflammatory and stress marker variations between women with breast cancer and those who did not have the disease. The study compared 498 women with breast cancer with an equal number of age-matched women without the disease. Serum samples were analyzed for matrix metalloproteinases, interleukins, heat shock proteins, tumor necrosis factor-alpha (TNF-a, a proinflammatory cytokine), nitric oxide, inducible nitric oxide synthase, malondialdehyde (MDA, a marker of oxidative stress), vitamins A, C and D, the antioxidant glutathione, and antioxidant enzymes superoxide dismutase (SOD) and catalase. Compared to women who did not have breast cancer, breast cancer patients exhibited overexpression of the inflammatory marker matrix metalloproteinase 9, the proinflammatory protein interleukin-1, heat shock protein 27 (which can be protective as well as destructive), TNF-a, nitric oxide, inducible nitric oxide synthase and MDA. Women with breast cancer had low levels of vitamins A, C and D, glutathione, catalase and SOD.